Drugs Health Pharma

FDA approves new Covid-19 jabs before fall and winter in the United States

The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which

Read More
Drugs Health Medical

World’s first lung cancer vaccine given to patient in UK as human trials begin

HQ team August 23, 2024: .An mRNA-based lung cancer vaccine is being tested for the first time on patients in the UK. Known

Read More
Drugs Health Medical

Mild concussions linked to long-term brain changes: Cambridge study

HQ Team August 22, 2024: Even a mild concussion could lead to long-term changes in the brain, according to a new study conducted

Read More
Drugs Health Medical

Accuracy and limitations of smartwatches and fitness trackers

HQ Team August 22, 2024: Smart devices such as watches and fitness trackers have surged in popularity, becoming essential tools for health and

Read More
Drugs Health Pharma

New study stirs up semglutide and suicide link debate

HQ Team August 22, 2024: A new study based on data from the World Health Organization’s records on adverse drug reactions found that

Read More
Drugs Health Pharma

UN body appeals for $18.5m aid to stop mpox spread among migrants in Africa

The International Organization for Migration has appealed for $18.5 million in global aid to provide healthcare services to migrants, internally displaced persons, and

Read More
Drugs Health Pharma

Body undergoes tectonic molecular shifts at age 44, 60: Stanford Medicine

Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart

Read More
Drugs Health Pharma

US drug regulator blocks Regeneron’s blood cancer therapy 

The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.

Read More
Drugs Medical Pharma

Basilea Pharmaceutica to get $1.25m license fee from Pfizer

Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed

Read More
Drugs Health Pharma

J&J plans to acquire Israel’s V-Wave by paying $600 million upfront

Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the

Read More
X